Early research (Phase 1)WithdrawnNCT05028946What this trial is testingOral Foralumab in Participants With Moderate to Severely Active Crohn's DiseaseWho this might be right forCrohn's Disease Tiziana Life Sciences LTD
Large-scale testing (Phase 3)Study completedNCT02136069What this trial is testingA Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) InhibitorsWho this might be right forUlcerative Colitis Hoffmann-La Roche 397
Testing effectiveness (Phase 2)Study completedNCT03934216What this trial is testingSafety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative ColitisWho this might be right forUlcerative Colitis Bristol-Myers Squibb 131
Testing effectiveness (Phase 2)Study completedNCT04504383What this trial is testingPN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis Chronic ModerateUlcerative Colitis Chronic Severe Protagonist Therapeutics, Inc. 169
Large-scale testing (Phase 3)Ended earlyNCT02118584What this trial is testingStudy for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III StudiesWho this might be right forUlcerative Colitis Hoffmann-La Roche 1,822
Testing effectiveness (Phase 2)Study completedNCT00737932What this trial is testingLaquinimod Phase IIa Study in Active Crohn's DiseaseWho this might be right forCrohn's Disease Teva Branded Pharmaceutical Products R&D, Inc. 180
Early research (Phase 1)Not Yet RecruitingNCT07768254What this trial is testingEvaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative ColitisWho this might be right forColitis, Ulcerative Helixon Biotechnology (Suzhou) Co., Ltd 32
Large-scale testing (Phase 3)Ended earlyNCT00307931What this trial is testingCertolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed InfliximabWho this might be right forCrohn's Disease UCB Pharma 16
Testing effectiveness (Phase 2)Ended earlyNCT06137183What this trial is testingEvaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis Genentech, Inc. 79
Early research (Phase 1)UnknownNCT01697670What this trial is testingPhotodynamic Therapy for Ulcerative ColitisWho this might be right forUlcerative Colitis University of Zurich 7
Large-scale testing (Phase 3)Study completedNCT00482092What this trial is testingEvaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's DiseaseWho this might be right forCrohn's Disease Mesoblast, Inc. 330
Testing effectiveness (Phase 2)WithdrawnNCT05471492What this trial is testingStudy to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn Disease Telavant, Inc.
Not applicableStudy completedNCT02229344What this trial is testingStudy of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in KoreaWho this might be right forColitis, Ulcerative Janssen Korea, Ltd., Korea 368
Large-scale testing (Phase 3)Study completedNCT02819635What this trial is testingEvaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)Who this might be right forUlcerative Colitis (UC) AbbVie 1,302
Large-scale testing (Phase 3)Study completedNCT02611817What this trial is testingEfficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)Who this might be right forCrohn's Disease Takeda 644
Large-scale testing (Phase 3)Study completedNCT01224171What this trial is testingStudy of Vedolizumab in Patients With Moderate to Severe Crohn's DiseaseWho this might be right forCrohn's Disease Millennium Pharmaceuticals, Inc. 416
Large-scale testing (Phase 3)Looking for participantsNCT07577843What this trial is testingJNJ-78934804 in Participants With Moderately to Severely Active Crohn's DiseaseWho this might be right forCrohn Disease Janssen Research & Development, LLC 460
Large-scale testing (Phase 3)Study completedNCT00552344What this trial is testingEvaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's DiseaseWho this might be right forCrohn Disease UCB BIOSCIENCES GmbH 403
Large-scale testing (Phase 3)Study completedNCT03290781What this trial is testingAn Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative ColitisWho this might be right forUlcerative Colitis Shire 366
Post-approval studies (Phase 4)Ended earlyNCT03591770What this trial is testingShingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on TofacitinibWho this might be right forInflammatory Bowel Diseases Boston Medical Center 15